WT
William D. Turner
Chief Regulatory Officer

William D. Turner insider trades: Vera Therapeutics (VERA) stock sales

Chief Regulatory Officer, Vera Therapeutics Last trade Feb 23, 2026 17 Form 4 filings
$1.4M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 23, 2026VERA↓ Sell$92K
Dec 15, 2025VERA↓ Sell$501K
Dec 8, 2025VERA↓ Sell$453K
Dec 3, 2025VERA↓ Sell$400K
Apr 6, 2022SRRA↓ Sell$240K
Mar 18, 2022SRRA↓ Sell$4K
Mar 17, 2022SRRA↓ Sell$128K
Feb 7, 2022SRRA↓ Sell$323K
Jan 26, 2022SRRA↓ Sell$135K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VERA insiders

Open-market trades in the last 12 months

About William D. Turner's insider trades

William D. Turner is Chief Regulatory Officer at Vera Therapeutics (VERA). Since Jan 26, 2022, William has reported no open-market purchases and 9 sales worth $2.3M on SEC Form 4. In the last 12 months: 4 sales ($1.4M).

Their filings also include grants and awards (8 filings), option exercises (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.